Lysine pyrrolation is a naturally-occurring covalent modification involved in the production of DNA mimic proteins. 2014

Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.

Covalent modification of proteins exerts significant effects on their chemical properties and has important functional and regulatory consequences. We now report the identification and verification of an electrically-active form of modified proteins recognized by a group of small molecules commonly used to interact with DNA. This previously unreported property of proteins was initially discovered when the γ-ketoaldehydes were identified as a source of the proteins stained by the DNA intercalators. Using 1,4-butanedial, the simplest γ-ketoaldehyde, we characterized the structural and chemical criteria governing the recognition of the modified proteins by the DNA intercalators and identified N(ε)-pyrrolelysine as a key adduct. Unexpectedly, the pyrrolation conferred an electronegativity and electronic properties on the proteins that potentially constitute an electrical mimic to the DNA. In addition, we found that the pyrrolated proteins indeed triggered an autoimmune response and that the production of specific antibodies against the pyrrolated proteins was accelerated in human systemic lupus erythematosus. These findings and the apparent high abundance of N(ε)-pyrrolelysine in vivo suggest that protein pyrrolation could be an endogenous source of DNA mimic proteins, providing a possible link connecting protein turnover and immune disorders.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009930 Organic Chemicals A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form. Organic Chemical,Chemical, Organic,Chemicals, Organic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene

Related Publications

Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
February 2008, Nucleic acids research,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
January 1992, Microbiology and immunology,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
May 2024, Molecular cell,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
June 2003, Antiviral research,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
August 2001, Protein engineering,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
December 1977, Science (New York, N.Y.),
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
January 2002, Environmental and molecular mutagenesis,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
January 2015, Frontiers in microbiology,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
November 2022, Chembiochem : a European journal of chemical biology,
Hiroaki Miyashita, and Miho Chikazawa, and Natsuki Otaki, and Yusuke Hioki, and Yuki Shimozu, and Fumie Nakashima, and Takahiro Shibata, and Yoshihisa Hagihara, and Shoichi Maruyama, and Noriyoshi Matsumi, and Koji Uchida
January 2001, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!